La cadena de opciones muestra datos clave de las opciones de acciones de SINTX Technologies a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para SINTX Technologies..

SINTX Technologies (NASDAQ:SINT) Bolsa, Cadena de Opciones

SINTX TECHNOLOGIES INC

SINTX Technologies

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

SINTX Techs

SINTX Technologies Inc

Sintana Energy Inc

SINTX Technologies Inc Warrants (14/05/2023)

Sintana Energy Inc Warrants (08/03/2024)

Sintokogio Ltd

Press Releases

General

SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates

News

SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition

Health Care

SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride

Legal

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent

SINTX Technologies Announces Successful Exercise of Warrants for $3.8 Million Gross Proceeds

SINTX Technologies to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025

SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics

UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

SINT

Aethlon Medical

Autonomix Medical

Bluejay Diagnostics

Biomerica

Check-Cap

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

GlucoTrack

HeartSciences

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Iridex

Lifeward

Spectral AI

NanoVibronix

ENDRA Life Sciences

enVVeno Medical Corporation - Common Stock

enVVeno Medical

PAVmed

Profusa

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Venus Concept

Catheter Precision

Beyond Air

Ascendiant Capital

Comments

SINTX Technologies

SINTX Technologies (SINT) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL